SciSparc Ltd.
NASDAQ: SPRC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Oz Adler
- Employees
- 2
- Headquarters
- Tel Aviv, Israel
- IPO year
- 2021
- Market cap
- $339.2K
- Website
- https://scisparc.com
Loading SPRC…
Loading profile data…Frequently asked questions about SPRC
What does SciSparc Ltd. (SPRC) do?
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated wi...
Where does SPRC trade?
SciSparc Ltd. (SPRC) trades on the NASDAQ Capital Market.
What sector is SPRC in?
SciSparc Ltd. (SPRC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of SciSparc Ltd.?
Oz Adler is the chief executive officer of SciSparc Ltd. (SPRC).
Where is SciSparc Ltd. headquartered?
SciSparc Ltd. is headquartered in Israel.
Does SPRC pay a dividend?
SciSparc Ltd. (SPRC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPRC go public?
SciSparc Ltd. (SPRC) completed its initial public offering in 2021.